Sensomedix is pioneering point-of-care technology to give surgeons immediate, actionable insights, eliminating the uncertainty of periprosthetic joint infections.
A 5-year mortality rate as high as 20% — PJI is more deadly than many cancers. Source: Increased Mortality Following Periprosthetic Joint Infection After Total Hip Arthroplasty: A Microbiologically Verified Nationwide Cohort of 1,611 PJI Revisions Kristensen, Nicolai K. et al. The Journal of Arthroplasty, DOI: 10.1016/j.arth.2025.06.011
A joint replacement is a life-changing procedure, but for up to 4% of patients, a dangerous complication lurks: Periprosthetic Joint Infection (PJI). Today's diagnostic methods are too slow, often taking days to confirm an infection. This critical delay leads to severe patient outcomes, including multiple surgeries, prolonged pain, and staggering healthcare costs exceeding €35,000 for a single complex case. Surgeons are forced to make irreversible decisions in the operating room with incomplete information. We believe there is a better way.